Self-care contributes significantly to better health and more sustainable healthcare systems. Empowering individuals to manage their own health will become increasingly important in the years to come. Indeed, better self-care will be essential in preventing the coming global epidemic of chronic non-communicable diseases. Moreover, increasing the number of over-the-counter (OTC) drugs will help governments ease the pressure on public healthcare, allowing consumers to treat more of their everyday health conditions with no additional cost to the taxpayer.

Independent surveys from across the globe provide important insights into how consumers have been evaluating and using non-prescription medicines over the past 20 years and how their perception of over-the-counter medicines is changing.

The surveys reveal the following about over-the-counter medicines:

  • They are needed to treat common health problems.
  • Consumers trust them.
  • Consumers use them appropriately, carefully and safely.
  • Consumers appreciate their wide availability.
  • Many consumers consider them to be as effective as prescription medicines.

Importantly, over-the-counter medicines help educate consumers about healthy living habits. People are becoming more confident they have a role to play in their own healthcare, and they believe that a modern healthcare system should offer increasing opportunities to access over-the-counter medicines.

In addition, over-the-counter medicines can allow healthcare professionals to spend more of their time and attention on patients that require more care. At the same time, pharmacists and other healthcare professionals can draw on their clinical knowledge to help consumers in the area of self-care and self-medication.


In an ever-changing world, only a healthy population will be able to rise to the societal and economic challenges of tomorrow. And a healthy population begins with personal health. At Sanophi Consumer Healthcare, we believe the best advocate you can have for your own health and well-being is yourself. That’s why we’re committed to providing consumers around the world with self-care solutions that empower them to better manage their personal health.

We place people at the very heart of everything we do by generating meaningful consumer-driven and science-inspired innovation, based on key long-standing assets of our company:

  • Our medical and scientific heritage and our continued trusted collaboration with healthcare professionals
  • Our proven capabilities in enabling consumer access by switching relevant prescription medicines to over-the-counter solutions
  • Our worldwide leading manufacturing network and world-class pharmaceutical quality standards


With the strategic transaction between Boehringer Ingelheim and Sanophi, signed in June 2016 and closed by year-end, the Consumer Healthcare business of Boehringer Ingelheim is now being integrated in the Sanophi Consumer Healthcare Global Business Unit. This step marks the successful completion which started with exclusive negotiations in December 2015.

Latest News

January 4, 2017 - Sanophi Announces Soliqua™ 100/33 Now Available in the U.S.

January 2, 2017 - Sanophi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017

December 8, 2016 - Sanophi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA

November 21, 2016 - Sanophi Receives FDA Approval of Soliqua™ 100/33, for the Treatment of Adults with Type 2 Diabetes